Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Cannabidiol nanoparticles with targeting molecules improve brain delivery and ease thinking and metabolic problems by influencing the gut-brain connection in an Alzheimer's model

Updated

Abstract

Evidence suggests a link between gut-brain axis dysfunction and metabolic disturbances in Alzheimer's disease.

  • Alzheimer's disease is associated with cognitive decline and neuronal loss.
  • Dysfunction in the gut-brain axis may contribute to the progression of Alzheimer's disease.
  • Metabolic disturbances could play a role in the development of Alzheimer's disease.
  • Cannabidiol has potential neuroprotective effects but faces challenges due to poor bioavailability and delivery to the brain.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free